Bank of India Limited (BOM:532149)

Theseus Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Interest Income on Loans	721,146	713,077	610,733	479,317	382,809	408,538
Interest Paid on Deposits	482,221	465,942	377,568	274,406	240,834	264,209
Net Interest Income	245,066	247,135	233,166	204,911	141,975	144,329
Net Interest Income Growth (YoY)	3.43%	5.99%	13.79%	44.33%	-1.63%	-6.28%
Gain (Loss) on Sale of Assets	2,030	2,030	284.57	1,341	2,773	602.06
Gain (Loss) on Sale of Investments	18,811	18,811	6,320	18,397	14,102	19,534
Other Non-Interest Income	78,937	70,207	55,727	52,374	63,230	48,830
Total Non-Interest Income	99,777	91,047	62,331	72,112	80,105	68,966
Non-Interest Income Growth (YoY)	63.91%	46.07%	-13.56%	-9.98%	16.15%	1.29%
Revenues Before Loan Losses	344,844	338,183	295,497	277,022	222,080	213,294
Provision for Loan Losses	38,572	40,500	40,504	72,300	44,643	70,453
Revenue	306,272	297,682	254,993	204,722	177,437	142,842
Revenue Growth (YoY)	21.21%	16.74%	24.56%	15.38%	24.22%	136.39%
Salaries and Employee Benefits	104,405	103,873	92,627	84,529	71,121	65,289
Occupancy Expenses	17,435	17,435	15,326	13,725	12,431	12,084
Selling, General & Administrative	6,449	6,449	5,931	5,885	4,089	3,724
Other Non-Interest Expense	47,042	44,342	39,178	39,596	34,059	28,966
Total Non-Interest Expense	174,095	169,972	151,242	144,163	120,889	111,246
EBT Excluding Unusual Items	132,177	127,710	103,752	60,560	56,548	31,596
Pretax Income	126,989	127,710	103,752	60,560	56,548	31,596
Income Tax Expense	32,062	32,189	38,086	22,166	21,675	10,790
Earnings From Continuing Operations	94,928	95,522	65,666	38,393	34,873	20,806
Minority Interest in Earnings	-32.23	-38.93	-21.12	-13.79	52.66	21.87
Net Income	94,896	95,483	65,645	38,380	34,926	20,828
Net Income to Common	94,896	95,483	65,645	38,380	34,926	20,828
Net Income Growth	37.71%	45.45%	71.04%	9.89%	67.69%	-
Basic Shares Outstanding	4,553	4,553	4,241	4,104	3,853	3,277
Diluted Shares Outstanding	4,553	4,553	4,241	4,104	3,853	3,278
Shares Change (YoY)	4.57%	7.35%	3.35%	6.51%	17.53%	0.86%
EPS (Basic)	20.84	20.97	15.48	9.35	9.07	6.36
EPS (Diluted)	20.84	20.97	15.48	9.35	9.07	6.35
EPS Growth	31.67%	35.48%	65.55%	3.14%	42.76%	-
Dividend Per Share	-	4.050	2.800	2.000	2.000	-
Dividend Growth	-	44.64%	40.00%	-	-	-
Effective Tax Rate	25.25%	25.20%	36.71%	36.60%	38.33%	34.15%

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.